John Irvin Manchester

Title: John Irvin Manchester: Innovator in Pharmaceutical Chemistry

Introduction

John Irvin Manchester is a notable inventor based in Waltham, MA (US). He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that have potential medicinal applications. With a total of 2 patents, his work focuses on innovative solutions for treating bacterial infections.

Latest Patents

Manchester's latest patents include "Heterocyclic urea derivatives and methods of use thereof." This patent describes compounds of formula (I) and their pharmaceutically acceptable salts. It outlines processes for their preparation, pharmaceutical compositions containing them, and their use as medicaments in the treatment of bacterial infections. Another significant patent is for "Alkyl urea substituted pyridines," which also details compounds of formula (I) and their pharmaceutically acceptable salts, along with similar processes and applications.

Career Highlights

John Irvin Manchester is currently associated with AstraZeneca AB, a leading global biopharmaceutical company. His work at AstraZeneca focuses on the research and development of innovative therapies that address critical health challenges.

Collaborations

Throughout his career, Manchester has collaborated with esteemed colleagues, including Brian A. Sherer and Gregory Steven Basarab. These collaborations have contributed to the advancement of his research and the successful development of his patented compounds.

Conclusion

John Irvin Manchester's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as an innovator in the field. His work continues to pave the way for new treatments in the fight against bacterial infections.